Methods and compositions for dosing of allogeneic chimeric antigen receptor t cells
MY215777AActive Publication Date: 2026-10-21ALLOGENE THERAPEUTICS INC +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2024004330
- Authority / Receiving Office
- MY · MY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2018-10-24
- Filing Date
- 2018-10-30
- Publication Date
- 2026-10-21
- Estimated Expiration
- 2038-10-30
Abstract
The present disclosure concerns dosages for the treatment of human patients susceptible to or diagnosed with a disease, such as cancer. Provided are methods for administering chimeric antigen receptor (CAR)-T cells. Also provided are compositions and articles of manufacture for use in the methods.
Need to check novelty before this filing date? Find Prior Art